# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# NCT02335281

# Study name

Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease (SFMT-IBD)

# Methods

RCT conducted in China

# Participants

# Inclusion criteria

- Severe IBD defined as HBI score ≥ 9
- Moderate IBD defined as 7 < HBI < 9
- Montreal classification: age > 14 years, Location L1–3, Behavior B1–3
- Ages 16–70 years

# Exclusion criteria

- Diarrhea activity scores < 3
- Severely active disease with perianal diseases
- Severely active disease with indication for surgery
- Diagnosis of IBD for the first time or in first year
- No history of 5-ASA, biologic (antibody), immunomodulatory, or corticosteroid therapy

# Interventions

# Experimental arm

Standardized FMT administered once to the midgut by nasojejunal tube

# Control arm

Traditional mesalazine treatment

# Outcomes

# Primary outcome

Clinical remission (defined as HBI score ≤ 4) at up to 1 year (endpoint of follow-up is the time of clinical recurrence)

# Secondary outcomes

Hospitalization days from administration to discharge when at clinical remission for up to 1 year

# Starting date

January 2015

# Contact information

Yanling Wei

Department of Gastroenterology, Research Institute of Surgery, Da Ping Hospital, The Third Military Medical University, Third Military Medical University

# Notes

Estimated enrollment: 40

# NCT02998112

# Study name

Fecal microbiota transplantation for ulcerative colitis through colonic transendoscopic enteral tubing

# Methods

RCT conducted in China

# Participants

# Inclusion criteria

- Active, moderate-to-severe UC (Mayo score > 6)

Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.